BRIEF-Anavex Receives FDA Clearance Of Its Ind Application For Blarcamesine In Fragile X Syndrome

2

Oct 15 (Reuters) – Anavex Life Sciences Corp: * ANAVEX RECEIVES FDA CLEARANCE OF ITS IND APPLICATION FOR BLARCAMESINE IN FRAGILE X SYNDROME * ANAVEX LIFE SCIENCES CORP – IND FOR BLARCAMESINE IN

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)